KPV is a highly active tripeptide (Lysine-Proline-Valine) representing the C-terminal fragment of alpha-melanocyte-stimulating hormone. Renowned in immunobiology research, KPV is investigated for its powerful anti-inflammatory and antimicrobial properties, acting to suppress NF-kB pathways in vitro.

"The tripeptide sequence of KPV retains the core immunomodulatory signaling of alpha-MSH, offering a highly stable template for evaluating cell recovery during inflammatory stress."

Detailed molecular data is cataloged at NCBI at the NCBI Melanocortin Portal and peer-reviewed journals are searchable at PubMed KPV Peptide Collection for advanced cellular immunology research. It works by blocking cytolytic transcription factor cascades.

Key Areas of Investigation:

• NF-kB Pathway Inhibition: Investigating intracellular transcription factor blockades.
• Antimicrobial Efficacy: Preclinical assays on cellular defense against Candida albicans.
• Intestinal Inflammation Integrity: Studies on epithelial cell barrier restoration in vitro.

This material is supplied exclusively as a lyophilized solid for laboratory research and analytical evaluation, and is strictly not for human or therapeutic use.